BioVeda China Fund
VC firm funding companies in China and the US
About This Fund
BioVeda China Fund is an institutional investor (Conventional VCs) founded in 2005 and headquartered in Huangpu, Shanghai, china. BioVeda China Fund (BVCF) is a venture capital firm. Geographies of interest include China and the US. Invests in Healthcare sectors operating in areas like HealthTech, Medical Devices, Diagnostics and Healthcare services. Notable portfolio companies include MicuRx Pharmaceuticals, Clarus Therapeutics, Quark Pharmaceuticals, Cathay Biotech. The firm has AUM worth $400 m. Practice areas include Investment Industry. The firm operates as Venture Capital Funds. Key investment sectors include Healthcare / HealthTech and Biotech / Biopharma. Geographic focus spans China and US. Notable portfolio companies: MicuRx Pharmaceuticals, Clarus Therapeutics, Quark Pharmaceuticals, Cathay Biotech.
Investment Focus
Preparing to pitch BioVeda China Fund?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →